Platelet aggregation in portal cirrhosis
- PMID: 4041
Platelet aggregation in portal cirrhosis
Abstract
Primary and secondary platelet aggregation in response to adenosine diphosphate was studied in 24 patients with portal (Laënnec) cirrhosis and compared with platelet aggregation in 14 normal subjects. In 12 patients with cirrhosis, platelet aggregation was diminished when compared to controls. Of the 12 patients with impaired aggregation, 6 had elevated levels of fibrinogen-fibrin degradation products (FDPs), 11 had thrombocytopenia, 10 had shortened euglobulin lysis times, 11 had prolonged bleeding times, 4 had hypofibrinogenemia, and all had prolonged thrombin clotting times. The data suggest that elevated levels of serum FDPs do not explain fully the impairment of platelet aggregation or the prolongation of the thrombin clotting time that was noted in patients with advanced liver disease. A possible explanation for the prolongation of the thrombin clotting time is the presence of "altered" plasma fibrinogen.
Similar articles
-
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.J Lab Clin Med. 1982 Feb;99(2):217-30. J Lab Clin Med. 1982. PMID: 7061918
-
In vitro and in vivo functions of thrombin-treated platelets.Thromb Haemost. 1976 Feb 29;35(1):151-66. Thromb Haemost. 1976. PMID: 785686
-
Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.Thromb Diath Haemorrh. 1974 Sep 30;32(1):216-31. Thromb Diath Haemorrh. 1974. PMID: 4454041
-
Actions of thrombin in the interstitium.J Thromb Haemost. 2016 Jan;14(1):40-7. doi: 10.1111/jth.13191. Epub 2015 Dec 29. J Thromb Haemost. 2016. PMID: 26564405 Review.
-
Assessing the risk of bleeding and clotting in cirrhosis.Clin Liver Dis (Hoboken). 2016 Feb 26;7(2):26-28. doi: 10.1002/cld.528. eCollection 2016 Feb. Clin Liver Dis (Hoboken). 2016. PMID: 31041022 Free PMC article. Review. No abstract available.
Cited by
-
Bleeding time in patients with hepatic cirrhosis.BMJ. 1990 Jul 7;301(6742):12-5. doi: 10.1136/bmj.301.6742.12. BMJ. 1990. PMID: 2383699 Free PMC article.
-
Acquired abnormalities of platelet function.N Engl J Med. 1991 Jun 6;324(23):1670-2. doi: 10.1056/NEJM199106063242313. N Engl J Med. 1991. PMID: 2030724 Free PMC article. No abstract available.
-
Platelet function in chronic liver disease: relationship to disease severity.Dig Dis Sci. 1979 Mar;24(3):197-202. doi: 10.1007/BF01308429. Dig Dis Sci. 1979. PMID: 456208
-
Clinical application of a new in vitro bleeding time device on surgical patients.Jpn J Surg. 1988 Jul;18(4):430-7. doi: 10.1007/BF02471469. Jpn J Surg. 1988. PMID: 2845175
-
Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged.Intern Emerg Med. 2010 Feb;5(1):7-12. doi: 10.1007/s11739-009-0302-z. Epub 2009 Aug 28. Intern Emerg Med. 2010. PMID: 19714443 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources